openPR Logo
Press release

Shift to home care to open a new chapter for the Metastatic Melanoma Cancer Diagnostics Market

01-20-2022 09:28 AM CET | Health & Medicine

Press release from: Persistence Market Research

Shift to home care to open a new chapter for the Metastatic

The Metastatic Melanoma Cancer Diagnostics Market is bound to grow at a remarkable rate in the forecast period. Vital Sign monitoring, in combination with wearables, does aid in symptoms check-in as well as education 24/7. There are also hand-held dongles being made available for attaching to smartphones to measure biomarkers for chronic ailments. This monitoring proves to be more cost-effective and convenient in comparison with in-person care. This trend would be prevalent in the healthcare vertical going forward.
Rising prevalence of metastatic melanoma cancer has been witnessed over the years. Verified therapeutics and diagnostics have a positive impact on treating the disease and extending the life span of patients. Improving sophistication in healthcare facilities and technological developments across the world are key factors expanding the market for metastatic melanoma cancer diagnostics. Government initiatives related to creating awareness for early diagnosis and treatment are also expected to drive demand for metastatic melanoma cancer diagnostics.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32446

The global metastatic melanoma cancer diagnostics market is estimated to be valued at US$ 2.9 Bn in 2021, and exhibit a CAGR of close to 8% over the forecast period (2021 – 2031).

Get a Customized Scope to Match Your Need Ask an Expert- sales@persistencemarketresearch.com

Key Takeaways from Market Study

PET scan test holds the highest value share in market under products, owing to advantages such as it shortens test time and provides accurate attenuation correction and fusion imaging, leading to an increase in diagnostic sensitivity and specificity.
By service provider, pathology laboratories hold a notable revenue share of more than half in the market.
Owing to rising cancer cases and increased awareness about cancer screening, the pathology laboratories segment is expected to experience lucrative growth among all service providers at a CAGR of 8.5% through 2031.

For critical insights, request for methodology @ https://www.persistencemarketresearch.com/methodology/32446

North America accounted for a share of more than 45% in 2020. It is the most lucrative market among all regions and is expected to experience significant growth over the next ten years.
Europe is the next dominating region with a market share of 35% in 2020, due to the flourishing cancer diagnostics industry in the region.
“Rising prevalence of metastatic melanoma disorders, increasing demand for non-invasive diagnostic therapy, and developments in metastatic melanoma cancer are is expected to drive market growth,” says a Persistence Market Research analyst.

COVID-19 Impact

According to the American Society of Clinical Oncology, the COVID-19 disease has tremendously disrupted healthcare facilities, globally. COVID-19 has also led to disruption in cancer services. The pandemic has resulted in heavy reduction in diagnosis, non-elective surgeries, and non-essential medical visits. Delay in visits for diagnosis can lead to delay in treatment for melanoma and other skin cancers, leading to serious health issues. All in all, the market witnessed sluggish growth due to the onset of the COVID-19 outbreak. However, as things have opened up, the market is set to recover some of its lost pace over the coming months and years.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/32446

What else is in the report?

Persistence Market Research offers a unique perspective and actionable insights on the metastatic melanoma cancer diagnostics market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021–2031, based on product (biopsy, chest X-ray, lymphoscintigraphy, ultrasound, CT or CAT (computed axial tomography) scans, MRI (magnetic resonance imaging) scans, and PET (positron emission tomography) scans)) and service provider (hospitals, pathology laboratories, and cancer research centers), across seven key regions of the world.

Complete Report Details@https://www.persistencemarketresearch.com/market-research/metastatic-melanoma-cancer-diagnostics-market.asp

Read More Trending "PMR Exclusive Article"-

PET MRI Market@ https://www.persistencemarketresearch.com/market-research/pet-mri-market.asp

Diagnostic Imaging Devices Market@ https://www.persistencemarketresearch.com/market-research/diagnostic-imaging-devices-market.asp

Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

About us-
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Shift to home care to open a new chapter for the Metastatic Melanoma Cancer Diagnostics Market here

News-ID: 2533249 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for Metastatic

Key Trends Reshaping the Metastatic Bone Disease Market: Advancements in Targete …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Metastatic Bone Disease Market Size Growth Forecast: What to Expect by 2025? The market size for metastatic bone disease has seen a quick expansion in the past few years. This market will increase from a value of $17.14 billion in 2024 to $18.88 billion in 2025, with a compound
Emerging Trends Influencing The Growth Of The Metastatic Urothelial Carcinoma Ma …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. How Big Is the Metastatic Urothelial Carcinoma Market Size Expected to Be by 2034? The market size for metastatic urothelial carcinoma has seen exponential growth recently. The market will expand from a worth of $1.18 billion in 2024 to $1.42 billion in 2025, with a compound annual growth rate (CAGR) of 20.2%.
Key Influencer in the Metastatic Cancer Drugs Market 2025: Surging Prevalence Of …
How Are the key drivers contributing to the expansion of the metastatic cancer drugs market? The escalation in the incidence of metastatic cancers will be a driving force for the expansion of the metastatic cancer drugs market. Metastatic cancer is a late-stage cancer that spreads across the body. As the number of metastatic cancer cases escalates, so does the creation of innovative drugs to treat various kinds of metastatic cancers. The
Prominent Metastatic Breast Cancer Treatment Market Trend for 2025: Advancements …
Which drivers are expected to have the greatest impact on the over the metastatic breast cancer treatment market's growth? The increasing occurrence of breast cancer is anticipated to boost the progression of the metastatic breast cancer treatment market. Breast cancer is a form of the disease that originates in the breast cells and is caused by abnormal cell growth in the breast, leading to the formation of a tumor. This alteration
Major Force in the Metastatic Bone Disease Market 2025: Impact Of Bone Cancer Pr …
How Will the Metastatic Bone Disease Market Grow, and What Is the Projected Market Size? The market size for metastatic bone disease has seen considerable growth in recent years. There is an expected increase from $17.14 billion in 2024 to $18.88 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%. The substantial growth during the historical period can be credited to factors like rising aging population, heightened cancer
Combination Therapy Strategies for Metastatic Cancer
Metastatic cancer, where cancer cells spread from the primary tumor to distant organs, presents significant treatment challenges. Combination therapy strategies have emerged as a powerful approach to enhance treatment efficacy, overcome resistance, and improve patient outcomes in metastatic cancer. Download Report: https://www.kuickresearch.com/report-cancer-antibody-combinations-therapy-cancer-antibody-combination-monoclonal-antibodies-combination-drug-conjugate-antibodies-combination One of the primary goals of combination therapy in metastatic cancer is to target both the primary tumor and metastatic sites. This comprehensive approach can improve overall disease control